Sintx Technologies (SINT) Liabilities and Shareholders Equity (2013 - 2026)
Sintx Technologies' (SINT) quarterly Liabilities and Shareholders Equity came in at $7.8 million in Q1 2026, down 31.78% year-on-year from $11.4 million in Q1 2025, and down 17.83% quarter-over-quarter from $9.5 million in Q4 2025.
Sintx Technologies (SINT) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends
Sintx Technologies' Liabilities and Shareholders Equity history runs 14 years deep, the most recent figure standing at $7.8 million for Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity fell 31.78% year-over-year to $7.8 million in Q1 2026; TTM through Mar 2026 was $37.9 million, a 20.2% decrease from a year earlier, with the FY2025 full-year figure at $9.5 million, up 0.99% from the prior year.
- Liabilities and Shareholders Equity declined to $7.8 million in Q1 2026 per SINT's latest filing, from $9.5 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $22.7 million in Q1 2023 and bottomed at $7.8 million in Q1 2026.
- The 5-year median for Liabilities and Shareholders Equity is $15.3 million (2024), against an average of $14.2 million.
- Across the five-year window, Liabilities and Shareholders Equity tumbled 41.44% in 2022 and climbed 19.95% in 2023, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $15.8 million in 2022, then slipped by 2.59% to $15.4 million in 2023, then sank by 38.74% to $9.4 million in 2024, then increased by 0.99% to $9.5 million in 2025, then retreated by 17.83% to $7.8 million in 2026.
- Per Business Quant, the three latest SINT Liabilities and Shareholders Equity figures stand at $7.8 million (Q1 2026), $9.5 million (Q4 2025), and $11.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.92 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.46 Bn |
| 10 | Sintx Technologies | 17,274.80 | -1.87 Mn | 144,000.00 | 7.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.81 Mn |
| Dec 31, 2025 | 9.51 Mn |
| Sep 30, 2025 | 11.36 Mn |
| Jun 30, 2025 | 9.20 Mn |
| Mar 31, 2025 | 11.45 Mn |
| Dec 31, 2024 | 9.41 Mn |
| Sep 30, 2024 | 11.30 Mn |
| Jun 30, 2024 | 15.30 Mn |
| Mar 31, 2024 | 17.56 Mn |
| Dec 31, 2023 | 15.37 Mn |
| Sep 30, 2023 | 15.51 Mn |
| Jun 30, 2023 | 19.10 Mn |
| Mar 31, 2023 | 22.65 Mn |
| Dec 31, 2022 | 15.77 Mn |
| Sep 30, 2022 | 14.56 Mn |
| Jun 30, 2022 | 17.49 Mn |
| Mar 31, 2022 | 18.88 Mn |
| Dec 31, 2021 | 21.84 Mn |
| Sep 30, 2021 | 24.87 Mn |
| Jun 30, 2021 | 26.42 Mn |